What is the price-to-earnings ratio of Cryosite?
The price-earnings ratio of Cryosite is currently 27.06.
Cryosite P/E 2024
Cryosite P/E
27.06
Ticker
CTE.AX
ISIN
AU000000CTE1
WKN
621943
As of Dec 18, 2024, Cryosite's P/E ratio was 27.06, a 30.22% change from the 20.78 P/E ratio recorded in the previous year.
The Cryosite P/E history
Cryosite Aktienanalyse
What does Cryosite do?
Cryosite Ltd was founded in Australia in 1999 and has since become a leading provider of services in the field of biological sample storage. The company specializes in the storage of blood, bone marrow, tissue, and other biological samples. Based in Sydney, Cryosite Ltd operates branches throughout Australia and is increasingly expanding into international business. Cryosite Ltd's business model is based on providing secure and reliable storage solutions for biological samples. This includes the collection, processing, and storage of biological samples, as well as their transportation and traceability. Cryosite Ltd offers its customers a comprehensive range of services to facilitate the storage and shipment of biological samples. This includes the development of customized archiving solutions tailored to individual needs. The company's various divisions include archiving solutions, clinical trials, stem cell therapy, biobanking, and blood banks. Cryosite Ltd's archiving solutions involve the setup, maintenance, and monitoring of biological samples in engraved tubes and boxes. The company offers a variety of cryopreservation systems to ensure that samples are stored under optimal conditions and can be retrieved within a specified timeframe. Additionally, the company also provides digital archiving solutions that enable efficient management and retrieval of stored data. Cryosite Ltd is also involved in clinical trials by assisting companies in conducting clinical studies. The company provides the necessary logistics and sample management to ensure that samples are properly processed, stored, and returned. It also provides comprehensive documentation to ensure the highest compliance standards. In the field of stem cell therapy, Cryosite Ltd offers a wide range of services that enable companies and researchers to store and process stem cells under optimal conditions. The company specializes in providing a wide range of application-oriented solutions and is a leader in the industry in supporting customers in the use of these technologies to enhance diagnostic and therapeutic discoveries. In the field of biobanking, Cryosite Ltd offers a comprehensive range of services to research institutes and organizations. Biobanking services include the setup, storage, monitoring, and tracking of biological samples for future research purposes. The company also offers services for the biobanking of clinical samples for disease diagnosis and evaluation. The company also operates blood banks that focus on blood donation and storage of blood products for efficient availability to patients. It offers a wide range of blood bank products and services to ensure effective blood supply for patients. Cryosite Ltd is committed to providing its customers with the highest standards in the storage and handling of blood products. In summary, Cryosite Ltd is a leading provider of storage and processing services for biological samples. The company has a long history of providing solutions for a wide range of applications in medical research and the medical industry. It strives to meet the highest standards and ensure that all samples are processed and stored efficiently and safely. Cryosite Ltd stays up to date with the latest technology and advanced processes to handle samples with maximum efficiency and quality. Cryosite ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Cryosite's P/E Ratio
The Price to Earnings (P/E) Ratio of Cryosite is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Cryosite's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Cryosite is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Cryosite’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Cryosite stock
How has the price-earnings ratio of Cryosite changed compared to last year?
The price-to-earnings ratio of Cryosite has increased by 30.22% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Cryosite high compared to other companies?
Yes, the price-to-earnings ratio of Cryosite is high compared to other companies.
How does an increase in the price-earnings ratio of Cryosite affect the company?
An increase in the price-earnings ratio of Cryosite would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Cryosite affect the company?
A decrease in the price-earnings ratio of Cryosite would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Cryosite?
Some factors that influence the price-earnings ratio of Cryosite are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Cryosite pay?
Over the past 12 months, Cryosite paid a dividend of 0.07 AUD . This corresponds to a dividend yield of about 8.24 %. For the coming 12 months, Cryosite is expected to pay a dividend of 0.07 AUD.
What is the dividend yield of Cryosite?
The current dividend yield of Cryosite is 8.24 %.
When does Cryosite pay dividends?
Cryosite pays a quarterly dividend. This is distributed in the months of October, October, March, October.
How secure is the dividend of Cryosite?
Cryosite paid dividends every year for the past 3 years.
What is the dividend of Cryosite?
For the upcoming 12 months, dividends amounting to 0.07 AUD are expected. This corresponds to a dividend yield of 8.24 %.
In which sector is Cryosite located?
Cryosite is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cryosite kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cryosite from 10/10/2024 amounting to 0.02 AUD, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.
When did Cryosite pay the last dividend?
The last dividend was paid out on 10/10/2024.
What was the dividend of Cryosite in the year 2023?
In the year 2023, Cryosite distributed 0.015 AUD as dividends.
In which currency does Cryosite pay out the dividend?
The dividends of Cryosite are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cryosite
Our stock analysis for Cryosite Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cryosite Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
